Unfinished Business For Blum’s Successor At CMS Includes Reworking Part D Protected Classes
Executive Summary
CMS’ Medicare chief Jonathan Blum will leave in mid-May and be succeeded by Center for Medicare and Medicaid Innovation Deputy Director Sean Cavanaugh. Other changes within the Medicare organization have also been announced.
You may also be interested in...
CMS’ Blum Assumes New High-Level Duties As ACA Implementation Proceeds
CMS Deputy Administrator Jonathan Blum is taking on some of the responsibilities previously handled by Acting Administrator Marilyn Tavenner as the agency faces deadlines in implementing key elements of the health reform law.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.